BRAF and neoplasm: NF-κBp 65, NF-κBp50, VEGF, HIF-2; VHL elevated mRNA level by 10.6; 13.5; 240.6; 11.5; 368.5 times found in tumors with mutation, respectively, compared to the primary tumor with the wild variant of the BRAF gene.